Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R P Warrell

Showing results (101-110 of 117) with videos related to

Pageof 12
Sort By:
Cancer Research|June 15, 1996
Metabolic phenotypes of retinoic acid and the risk of lung cancerJ R Rigas, V A Miller, Z F Zhang, et al.
The Journal of Clinical Investigation|November 7, 2001
Histone deacetylase inhibitors induce remission in transgenic models of therapy-resistant acute promyelocytic leukemiaL Z He, T Tolentino, P Grayson, et al.
Blood|August 26, 1998
Arsenic trioxide and melarsoprol induce programmed cell death in myeloid leukemia cell lines and function in a PML and PML-RARalpha independent mannerZ G Wang, R Rivi, L Delva, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2000
Initial clinical trial of a high-affinity retinoic acid receptor ligand (LGD1550)S L Soignet, V A Miller, D G Pfister, et al.
Journal of the National Cancer Institute|December 1, 1993
Constitutive variability in the pharmacokinetics of the natural retinoid, all-trans-retinoic acid, and its modulation by ketoconazoleJ R Rigas, P A Francis, J R Muindi, et al.
Cancer Research|February 15, 1990
Phase I clinical and pharmacological study of merbaroneJ J Dimaggio, R P Warrell, J Muindi, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Clinical and pharmacology study of chloroquinoxaline sulfonamide given on a weekly scheduleJ R Rigas, P A Francis, V A Miller, et al.
The New England Journal of Medicine|May 26, 1991
Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid)R P Warrell, S R Frankel, W H Miller, et al.
Leukemia|February 1, 1995
Sequential targeted therapy for relapsed acute promyelocytic leukemia with all-trans retinoic acid and anti-CD33 monoclonal antibody M195J G Jurcic, P C Caron, W H Miller, et al.
Leukemia|April 30, 2004
Acute promyelocytic leukemia cell line AP-1060 established as a cytokine-dependent culture from a patient clinically resistant to all-trans retinoic acid and arsenic trioxideY Sun, S H Kim, D-C Zhou, et al.
Pageof 12

Showing results (101-110 of 117) with videos related to

Sort By:
Pageof 12
Cancer Research|June 15, 1996
Metabolic phenotypes of retinoic acid and the risk of lung cancerJ R Rigas, V A Miller, Z F Zhang, et al.
The Journal of Clinical Investigation|November 7, 2001
Histone deacetylase inhibitors induce remission in transgenic models of therapy-resistant acute promyelocytic leukemiaL Z He, T Tolentino, P Grayson, et al.
Blood|August 26, 1998
Arsenic trioxide and melarsoprol induce programmed cell death in myeloid leukemia cell lines and function in a PML and PML-RARalpha independent mannerZ G Wang, R Rivi, L Delva, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2000
Initial clinical trial of a high-affinity retinoic acid receptor ligand (LGD1550)S L Soignet, V A Miller, D G Pfister, et al.
Journal of the National Cancer Institute|December 1, 1993
Constitutive variability in the pharmacokinetics of the natural retinoid, all-trans-retinoic acid, and its modulation by ketoconazoleJ R Rigas, P A Francis, J R Muindi, et al.
Cancer Research|February 15, 1990
Phase I clinical and pharmacological study of merbaroneJ J Dimaggio, R P Warrell, J Muindi, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Clinical and pharmacology study of chloroquinoxaline sulfonamide given on a weekly scheduleJ R Rigas, P A Francis, V A Miller, et al.
The New England Journal of Medicine|May 26, 1991
Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid)R P Warrell, S R Frankel, W H Miller, et al.
Leukemia|February 1, 1995
Sequential targeted therapy for relapsed acute promyelocytic leukemia with all-trans retinoic acid and anti-CD33 monoclonal antibody M195J G Jurcic, P C Caron, W H Miller, et al.
Leukemia|April 30, 2004
Acute promyelocytic leukemia cell line AP-1060 established as a cytokine-dependent culture from a patient clinically resistant to all-trans retinoic acid and arsenic trioxideY Sun, S H Kim, D-C Zhou, et al.
Pageof 12